title: GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma.
authors: Pacific Coast Medical Group, Manhattan Beach, CA.
authors: Ronald J
authors: RJ
authors: Ruby
authors: Pacific Coast Medical Group, Manhattan Beach, CA.
authors: John P
authors: JP
authors: Armato
authors: Histology and Imaging, Novo Nordisk A/S, Bagsvaerd, Denmark.
authors: Charles
authors: C
authors: Pyke
authors: Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, CA momofmax@mac.com.
authors: Anne L
authors: AL
authors: Peters
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D007340:Insulinoma / Q000097:blood / Q000150:complications* / Q000601:surgery; D000069450:Liraglutide; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood / Q000150:complications* / Q000601:surgery; D018027:Receptors, Glucagon / Q000819:agonists* / Q000032:analysis; D012720:Severity of Illness Index
chemical_list: C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007328:Insulin; D018027:Receptors, Glucagon; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1